Effects of step-wise increases in dietary carbohydrate on circulating saturated fatty acids and palmitoleic acid in adults with metabolic syndrome

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Volk, Brittanie M ^a   Kunces, Laura J ^a   Freidenreich, Daniel J ^a   Kupchak, Brian R ^a   Saenz, Catherine ^a   Artistizabal, Juan C ^a   Fernandez, Maria Luz ^a   Bruno, Richard S ^b   Maresh, Carl M ^a   Kraemer, William J ^a   Phinney, Stephen D ^c   Volek, Jeff S ^a,b  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; KETONE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOUNSATURATED FATTY ACID; OLEIC ACID; PALMITOLEIC ACID; PHOSPHOLIPID; SATURATED FATTY ACID; TRIACYLGLYCEROL; CARBOHYDRATE DIET; FATTY ACID;

ADULT; AGED; ARTICLE; BODY MASS; CALORIC INTAKE; CARBOHYDRATE INTAKE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; EXPERIMENTAL DESIGN; FAT INTAKE; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LIPID ANALYSIS; LIPID COMPOSITION; LOW CALORY DIET; LUNG GAS EXCHANGE; MALE; METABOLIC SYNDROME X; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PHOSPHOLIPID BLOOD LEVEL; PROTEIN INTAKE; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION; ADMINISTRATION AND DOSAGE; ADVERSE EFFECTS; BLOOD; CARBOHYDRATE DIET; MIDDLE AGED; RISK FACTOR;

ADULT; AGED; DIETARY CARBOHYDRATES; FATTY ACIDS; FATTY ACIDS, MONOUNSATURATED; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS;

EID: 84913534683     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113605     Document Type: Article

References (36)

1. U.S. Department of Agriculture anepartment of Agriculture and U.S. Department of Health and Human Services. Dietary Guidelines for Americans, 2010. 7th Edition, Washington, DC: U.S. Government Printing Office, December 2010
2. Jakobsen MU, O'Reilly EJ, Heitmann BL, Pereira MA, Balter K, et al. (2009) Major types of dietary fat and risk of coronary heart disease: A pooled analysis of 11 cohort studies. Am J Clin Nutr 89(5): 1425-1432
3. Aarsland A, Wolfe RR (1998) Hepatic secretion of VLDL fatty acids during stimulated lipogenesis in men. J Lipid Res 39(6): 1280-6
4. Schwarz JM, Linfoot P, Dare D, Aghajanian K (2003) Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. Am J Clin Nutr 77(1): 43-50
5. Petersen KF, Dufour S, Savage DB, Bilz S, Solomon G, et al. (2007) The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc Natl Acad Sci U S A 104(31): 12587-94
6. Marques-Lopes I, Ansorena D, Astiasaran I, Forga L, Martinez JA (2001) Postprandial de novo lipogenesis and metabolic changes induced by a high-carbohydrate, low-fat meal in lean and overweight men. Am J Clin Nutr 73(2): 253-61
7. Kotronen A, Velagapudi VR, Yetukuri L, Westerbacka J, Bergholm R, et al. (2009) Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations. Diabetologia 52(4): 684-690
8. Warensjö E, Risérus U, Vessby B (2005) Fatty acid composition of serum lipids predicts the development of the metabolic syndrome in men. Diabetologia 48(10): 1999-2005
9. Zong G, Zhu J, Sun L, Ye X, Lu L, et al. (2013) Associations of erythrocyte fatty acids in the de novo lipogenesis pathway with risk of metabolic syndrome in a cohort study of middle-aged and older Chinese. Am J Clin Nutr 98(2): 319-26
10. Hodge AM, English DR, O'Dea K, Sinclair AJ, Makrides M, et al. (2007) Plasma phospholipid and dietary fatty acids as predictors of type 2 diabetes: interpreting the role of linoleic acid. Am J Clin Nutr 86(1): 189-97
11. Wang L, Folsom AR, Zheng ZJ, Pankow JS, Eckfeldt JH; et al. (2003) Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr 78(1): 91-8
12. Krö ger J, Zietemann V, Enzenbach C, Weikert C, Jansen EH, et al. (2011) Erythrocyte membrane phospholipid fatty acids, desaturase activity, and dietary fatty acids in relation to risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Am J Clin Nutr 93,; 1 127-42
13. Patel PS, Sharp SJ, Jansen E, Luben RN, Khaw KT, et al. (2010) Fatty acids measured in plasma and erythrocyte-membrane phospholipids and derived by food-frequency questionnaire and the risk of newonset type 2 diabetes: A pilot study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk cohort. Am J Clin Nutr 92(5): 1214-22
14. Vessby B, Aro A, Skarfors E, Berglund L, Salminen I, et al. (1994) The risk to develop NIDDM is related to the fatty acid composition of the serum cholesterol esters. Diabetes 43(11): 1353-7
15. Mahendran Y, Agren J, Uusitupa M, Cederberg H, Vangipurapu J, et al. (2013) Association of erythrocyte membrane fatty acids with changes in glycemia and risk of type 2 diabetes. Am J Clin Nutr. 99(1): 79-85
16. Miettinen TA, Naukkarinen V, Huttenen JK, Mattila S, Kumlin T (1982) Fatty-acid composition of serum lipids predicts myocardial infarction. Br Med J (Clin Res Ed) 285: 993-6
17. Simon JA, Hodgkins ML, Browner WS, Neuhaus JM, Bernert JT, et al. (1995) Serum Fatty Acids and the Risk of Coronary Heart Disease. Am J Epidemiol 142: 469-76
18. Wang L, Folsom AR, Eckfeldt (2003) Plasma fatty acid composition and incidence of coronary heart disease in middle aged adults: The Atherosclerosis Risk in Communities (ARIC) Study. Nut Metab Cardiovasc Dis 13: 256-66
19. Yamagishi K, Nettleton JA, Folsom AR, ARIC Study Investigators (2008) Plasma fatty acid composition and incident heart failure in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 156: 965-74
20. Chowdhury R, Warnakula S, Kunutsor S, Crowe F, Ward HA, et al. (2014) Association of dietary, circulating, and supplement fatty acids with coronary risk: A systematic review and meta-analysis. Ann Intern Med 160(6): 398-406
21. Chavarro JE, Kenfield SA, Stampfer MJ, Loda M, Campos H, et al. (2013) Blood levels of saturated and monounsaturated fatty acids as markers of de novo lipogenesis and risk of prostate cancer. Am J Epidemiol 178(8): 1246-55
22. Raatz SK, Bibus D, Thomas W, Kris-Etherton P (2001) Total fat intake modifies plasma fatty acid composition in humans. J Nutr 131(2): 231-234
23. King IB, Lemaitre RN, Kestin M (2006) Effect of a low-fat diet on fatty acid composition in red cells, plasma phospholipids, and cholesterol esters: investigation of a biomarker of total fat intake. Am J Clin Nutr 83(2): 227-236
24. Forsythe CE, Phinney SD, Feinman RD, Volk BM, Freidenreich D, et al. (2010) Limited effect of dietary saturated fat on plasma saturated fat in the context of a low carbohydrate diet. Lipids 45(10): 947-962
25. Forsythe CE, Phinney SD, Fernandez ML, Quann EE, Wood RJ, et al. (2008) Comparison of low fat and low carbohydrate diets on circulating fatty acid composition and markers of inflammation. Lipids 43(1): 65-77
26. Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28(7): 412-9
27. Kunesova M, Hainer V, Tvrzicka E, Phinney SD, Stich V, et al. (2002) Assessment of dietary and genetic factors influencing serum and adipose fatty acid composition in obese female identical twins. Lipids. 37: 27-32
28. Klein-Platat C, Drai J, Oujaa M, Schlienger JL, Simon C (2005) Plasma fatty acid composition is associated with the metabolic syndrome and low-grade inflammation in overweight adolescents. Am J Clin Nutr. 82: 1178-84
29. Paillard F, Catheline D, Duff FL, Bouriel M, Deugnier Y, et al. (2008) Plasma palmitoleic acid, a product of stearoyl-coA desaturase activity, is an independent marker of triglyceridemia and abdominal adiposity. Nutr Metab Cardiovasc Dis 18: 436-40
30. Zong G, Ye XW, Sun L, Li HX, Yu ZJ, et al. (2012) Associations of erythrocyte palmitoleic acid with adipokines, inflammatory markers, and the metabolic syndrome in midcdle-aged and older Chinese. Am J Clin Nutr. 96: 970-76
31. Petersson H, Lind L, Hulthe J, Elmgren A, Cederholm T, et al. (2009) Relationships between serum fatty acid composition and multiple markers of inflammation and endothelial function in an elderly population. Atherosclerosis 203(1): 298-303
32. Djoussé L, Matthan NR, Lichtenstein AH, Gaziano JM (2012) Red blood cell membrane concentration of cis-palmitoleic and cis-vaccenic acids and risk of coronary heart disease. Am J Cardiol 110: 539-44
33. Djoussé L, Weir NL, Hanson NQ, Tsai MY, Gaziano JM (2012) Plasma phospholipid concentration of cis-palmitoleic acid and risk of heart failure. Circ Heart Fail 5: 703-9
34. Phinney SD, Bistrian BR, Evans WJ, Gervino E, Blackburn GL (1983) The human metabolic response to chronic ketosis without caloric restriction: preservation of submaximal exercise capability with reduced carbohydrate oxidation. Metabolism 32(8): 769-76
35. Bonadonna RC, Groop LC, Zych K, Shank M, DeFronzo RA (1990) Dose-dependent effect of insulin on plasma free fatty acid turnover and oxidation in humans. Am J Physiol 259: E736-E750
36. Volek JS, Sharman MJ, Forsythe CE (2005) Modification of lipoproteins by very low-carbohydrate diets. J Nutr 135(6): 1339-42.